Donald Arnold

Donald Arnold is a Professor in the Department of Medicine at McMaster University, specializing in hematological disorders with a focus on platelet-related conditions. His research spans immune-mediated thrombocytopenias, vaccine-induced complications, and transfusion medicine, making significant contributions to understanding and managing these complex conditions.

Dr. Arnold's research interests center on immune thrombocytopenia (ITP), heparin-induced thrombocytopenia (HIT), and vaccine-induced immune thrombotic thrombocytopenia (VITT). His work has pioneered diagnostic approaches and treatment strategies for these platelet disorders, particularly focusing on antibody-mediated mechanisms and clinical management protocols. He has led major studies on bleeding outcomes in thrombocytopenic patients and developed consensus guidelines for diagnosis and treatment.

His recent publications demonstrate a clear trend toward understanding the pathophysiology of anti-platelet factor 4 antibody disorders, developing diagnostic algorithms, and creating management strategies for critical bleeding events. His work bridges laboratory science with clinical practice, particularly evident in his leadership of the McMaster ITP Registry and contributions to international consensus guidelines through the ISTH.

Dr. Arnold has been instrumental in establishing the McMaster Platelet Immunology Laboratory as Canada's national testing center for vaccine-related blood clots, receiving significant funding from the Public Health Agency of Canada. His research collaborations extend through the Canadian Transfusion Trials Group, which received $2.3 million from Canadian Blood Services for transfusion medicine research.

His clinical expertise is reflected in numerous publications addressing practical aspects of managing patients with complex platelet disorders, including perioperative considerations, transfusion practices, and emergency management of bleeding complications in thrombocytopenic patients.